2022 American Transplant Congress
Adjustment for Race and Ethnicity Does Not Change Transplant Center Outcome Metrics for Liver Recipients
1Emory University, Atlanta, GA, 2University of Miami, Miami, FL
*Purpose: Concerns have been raised about whether transplant center metrics should be adjusted for race and ethnicity given long-standing disparities in outcomes. Proponents of adjustment…2022 American Transplant Congress
Outcomes in Elderly Black Renal Transplant Recipients Receiving Basiliximab Induction and Early Steroid Withdrawal
University of Maryland Medical Center, Baltimore, MD
*Purpose: Black renal transplant recipients (RTR) carry a higher risk of rejection (BPAR) and graft loss due to immunologic and non-immunologic factors. Lymphocyte depleting induction…2022 American Transplant Congress
Recipient Race Modifies the Association Between Obesity and Long Term Graft Outcomes After Renal Transplantation
*Purpose: Both donor and recipient obesity are associated with adverse outcomes after transplant. Whether obesity, defined using body mass index (BMI), has different implications on…2022 American Transplant Congress
Development of a Culturally Sensitive Chatbot to Inform Living Donor Candidates of African Ancestry About Apol1 Genetic Testing
*Purpose: Living kidney donor candidates of African ancestry are increasingly asked to undergo Apolipoprotein L1 (APOL1) genetic testing to better understand their risk of kidney…2022 American Transplant Congress
Racial Disparities in Preemptive Kidney Transplantation Beyond Listing Estimated Glomerular Filtration Rate
*Purpose: Given recent attention on the impact of the race coefficient in equations for estimated glomerular filtration rate (eGFR) on racial disparities in kidney transplantation,…2022 American Transplant Congress
The Role of Gut Microbiota in Tacrolimus Blood Level Fluctuation, Time in Therapeutic Range and AlloSure Donor Derived Cell-Free DNA, Controlling for CYP3A5
1George Mason University, Arlington, VA, 2George Washington University Hospital, Washington, DC
*Purpose: High tacrolimus variability (TV), low time in therapeutic range (TTR) and high percentage of donor derived cell-free DNA (dd-cfDNA) are associated with acute kidney…2022 American Transplant Congress
Race Misclassification in Kidney Transplantation Research
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Recently, the use of socially constructed “race” in kidney disease research has received national attention partly because of the research bias created when race…2022 American Transplant Congress
Impact of African American Race on Lcp-Tac Dosing and Clinical Outcomes
Medical University of South Carolina, Charleston, SC
*Purpose: The goal of this study was to assess the impact of African American (AA) race on the conversion ratio from Tac-IR to LCP-Tac, while…2022 American Transplant Congress
Use of New 2021 CKD-EPI as an Endpoint in Transplant Trials May Significantly Influence Observations
1University of Cincinnati, Cincinnati, OH, 2CCHMC, Cincinnati, OH
*Purpose: GFR equations have recently been modified primarily to avoid disadvantaging black populations. The purpose of this study was to evaluate renal function and the…2022 American Transplant Congress
Impact of End-of-Chain Kidney Allocation on Access to Kidney Transplantation of Minority Patients: Implications for Reducing Disparities
*Purpose: Disparities in access to kidney transplantation (KT) among non-White patients is well-known, especially as it relates to living donor kidney transplantation (LDKT). We investigated…
- 1
- 2
- 3
- …
- 23
- Next Page »